ZRX1, the first EGFR inhibitor-capecitabine based combi-molecule, requires carboxylesterase-mediated hydrolysis for optimal activity
Ait-Tihyaty, Maria, Rachid, Zakaria, Larroque-Lombard, Anne-Laure, Jean-Claude, Bertrand J.Volume:
31
Language:
english
Journal:
Investigational New Drugs
DOI:
10.1007/s10637-013-0008-y
Date:
December, 2013
File:
PDF, 706 KB
english, 2013